299 related articles for article (PubMed ID: 23973798)
1. Oxidized-phospholipids in reconstituted high density lipoprotein particles affect structure and function of recombinant paraoxonase 1.
Kar S; Patel MA; Tripathy RK; Bajaj P; Pande AH
Biochim Biophys Acta; 2013 Dec; 1831(12):1714-20. PubMed ID: 23973798
[TBL] [Abstract][Full Text] [Related]
2. Oxidized phospholipid content destabilizes the structure of reconstituted high density lipoprotein particles and changes their function.
Kar S; Patel MA; Tripathy RK; Bajaj P; Suvarnakar UV; Pande AH
Biochim Biophys Acta; 2012 Sep; 1821(9):1200-10. PubMed ID: 22634518
[TBL] [Abstract][Full Text] [Related]
3. ApoE induces serum paraoxonase PON1 activity and stability similar to ApoA-I.
Gaidukov L; Viji RI; Yacobson S; Rosenblat M; Aviram M; Tawfik DS
Biochemistry; 2010 Jan; 49(3):532-8. PubMed ID: 20025294
[TBL] [Abstract][Full Text] [Related]
4. Lipid complex of apolipoprotein A-I mimetic peptide 4F is a novel platform for paraoxonase-1 binding and enhancing its activity and stability.
Mishra VK; Palgunachari MN; McPherson DT; Anantharamaiah GM
Biochem Biophys Res Commun; 2013 Jan; 430(3):975-80. PubMed ID: 23261466
[TBL] [Abstract][Full Text] [Related]
5. Evidence that phospholipids play a key role in pre-beta apoA-I formation and high-density lipoprotein remodeling.
Rye KA; Duong M; Psaltis MK; Curtiss LK; Bonnet DJ; Stocker R; Barter PJ
Biochemistry; 2002 Oct; 41(41):12538-45. PubMed ID: 12369845
[TBL] [Abstract][Full Text] [Related]
6. Human apolipoprotein A-II enrichment displaces paraoxonase from HDL and impairs its antioxidant properties: a new mechanism linking HDL protein composition and antiatherogenic potential.
Ribas V; Sánchez-Quesada JL; Antón R; Camacho M; Julve J; Escolà-Gil JC; Vila L; Ordóñez-Llanos J; Blanco-Vaca F
Circ Res; 2004 Oct; 95(8):789-97. PubMed ID: 15388641
[TBL] [Abstract][Full Text] [Related]
7. The catalytic histidine dyad of high density lipoprotein-associated serum paraoxonase-1 (PON1) is essential for PON1-mediated inhibition of low density lipoprotein oxidation and stimulation of macrophage cholesterol efflux.
Rosenblat M; Gaidukov L; Khersonsky O; Vaya J; Oren R; Tawfik DS; Aviram M
J Biol Chem; 2006 Mar; 281(11):7657-65. PubMed ID: 16407304
[TBL] [Abstract][Full Text] [Related]
8. High affinity, stability, and lactonase activity of serum paraoxonase PON1 anchored on HDL with ApoA-I.
Gaidukov L; Tawfik DS
Biochemistry; 2005 Sep; 44(35):11843-54. PubMed ID: 16128586
[TBL] [Abstract][Full Text] [Related]
9. Defective metabolism of oxidized phospholipid by HDL from people with type 2 diabetes.
Mastorikou M; Mackness M; Mackness B
Diabetes; 2006 Nov; 55(11):3099-103. PubMed ID: 17065348
[TBL] [Abstract][Full Text] [Related]
10. Evidence that hepatic lipase and endothelial lipase have different substrate specificities for high-density lipoprotein phospholipids.
Duong M; Psaltis M; Rader DJ; Marchadier D; Barter PJ; Rye KA
Biochemistry; 2003 Nov; 42(46):13778-85. PubMed ID: 14622025
[TBL] [Abstract][Full Text] [Related]
11. Structural and Functional Changes of Reconstituted High-Density Lipoprotein (HDL) by Incorporation of α-synuclein: A Potent Antioxidant and Anti-Glycation Activity of α-synuclein and apoA-I in HDL at High Molar Ratio of α-synuclein.
Cho KH
Molecules; 2021 Dec; 26(24):. PubMed ID: 34946565
[TBL] [Abstract][Full Text] [Related]
12. Systemic inflammation, intestine, and paraoxonase-1.
Vakili L; Navab KD; Shabihkhani M; Pourtabatabaei N; Vazirian S; Barseghian Z; Seyedali S; Hough G
Adv Exp Med Biol; 2014; 824():83-8. PubMed ID: 25038995
[TBL] [Abstract][Full Text] [Related]
13. The effect of HDL mimetic peptide 4F on PON1.
Vakili L; Hama S; Kim JB; Tien D; Safarpoor S; Ly N; Vakili G; Hough G; Navab M
Adv Exp Med Biol; 2010; 660():167-72. PubMed ID: 20221879
[TBL] [Abstract][Full Text] [Related]
14. Characterization of apolipoprotein A-I peptide phospholipid interaction and its effect on HDL nanodisc assembly.
Patel H; Ding B; Ernst K; Shen L; Yuan W; Tang J; Drake LR; Kang J; Li Y; Chen Z; Schwendeman A
Int J Nanomedicine; 2019; 14():3069-3086. PubMed ID: 31118623
[No Abstract] [Full Text] [Related]
15. Protective effect of high density lipoprotein associated paraoxonase. Inhibition of the biological activity of minimally oxidized low density lipoprotein.
Watson AD; Berliner JA; Hama SY; La Du BN; Faull KF; Fogelman AM; Navab M
J Clin Invest; 1995 Dec; 96(6):2882-91. PubMed ID: 8675659
[TBL] [Abstract][Full Text] [Related]
16. The charge and structural stability of apolipoprotein A-I in discoidal and spherical recombinant high density lipoprotein particles.
Sparks DL; Lund-Katz S; Phillips MC
J Biol Chem; 1992 Dec; 267(36):25839-47. PubMed ID: 1464598
[TBL] [Abstract][Full Text] [Related]
17. Coincubation of PON1, APO A1, and LCAT increases the time HDL is able to prevent LDL oxidation.
Hine D; Mackness B; Mackness M
IUBMB Life; 2012 Feb; 64(2):157-61. PubMed ID: 22184096
[TBL] [Abstract][Full Text] [Related]
18. Paraoxonase, a cardioprotective enzyme: continuing issues.
Getz GS; Reardon CA
Curr Opin Lipidol; 2004 Jun; 15(3):261-7. PubMed ID: 15166781
[TBL] [Abstract][Full Text] [Related]
19. Associations between HDL oxidation and paraoxonase-1 and paraoxonase-1 gene polymorphisms in families affected by familial combined hyperlipidemia.
Liu ML; James RW; Ylitalo K; Taskinen MR
Nutr Metab Cardiovasc Dis; 2004 Apr; 14(2):81-7. PubMed ID: 15242240
[TBL] [Abstract][Full Text] [Related]
20. Activation of paraoxonase 1 is associated with HDL remodeling ex vivo.
Gugliucci A
Clin Chim Acta; 2014 Feb; 429():38-45. PubMed ID: 24280342
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
